Heron Therapeutics Inc (HRTX)

07:28 AM

Heron Therapeutics (NASDAQ:HRTX) Announces Quarterly Earnings Results - MarketBeat

07:28 AM

05:52 AM

Insider Buying: Heron Therapeutics, Inc. (NASDAQ:HRTX) Director Purchases 1,766,546 Shares of Stock - MarketBeat

05:52 AM

02:47 AM

Heron Therapeutics’ Earnings Call Highlights Growth and Strategy - TipRanks

02:47 AM

07:17 AM

Informed Momentum Co LLC Invests $768,000 in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

07:17 AM

Aug 13, 2025

Needham & Company LLC Cuts Heron Therapeutics (NASDAQ:HRTX) Price Target to $3.00 - MarketBeat

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing - MSN

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics (NASDAQ:HRTX) Lowered to Hold Rating by Wall Street Zen - MarketBeat

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Soars 13.74% on Insider Buying, Strategic Moves - AInvest

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Signs Agreement with Patheon - MSN

Aug 13, 2025

Aug 13, 2025

Rubric Capital and Director Morgan Make Significant Investments in Heron Therapeutics - AInvest

Aug 13, 2025

Aug 13, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing and Board Changes - AInvest

Aug 13, 2025

Aug 12, 2025

Rubric capital buys Heron Therapeutics (HRTX) shares worth $3.5m - Investing.com

Aug 12, 2025

Aug 12, 2025

Rubric capital buys Heron Therapeutics (HRTX) shares worth $3.5m By Investing.com - Investing.com UK

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics enters board agreement and completes refinancing transactions By Investing.com - Investing.com Nigeria

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics: Insider Confidence and Strategic Entry Points in a Volatile Market - AInvest

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics enters board agreement and completes refinancing transactions - Investing.com

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics enters supply agreement with Patheon and Thermo Fisher - Investing.com

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics Convertible Notes - Leerink Partners

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics Senior Credit Facility - Leerink Partners

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics Reports Strong Q2 Revenue Growth Amid Inventory Challenges and Transition to Permanent J Code for Zenerlef - AInvest

Aug 12, 2025

Aug 12, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025

Aug 11, 2025

Heron Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025

Aug 09, 2025

Heron Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 09, 2025

Aug 09, 2025

Jefferies Financial Group Inc. Buys Shares of 322,600 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates - MSN

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics Announces Strategic Financial Initiatives - The Globe and Mail

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics 2025 Q2 Earnings Record Net Income and Revenue Growth - AInvest

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics' Q2 Earnings Miss: A Misunderstood Catalyst for Long-Term Growth? - AInvest

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics' Q2 2025 Earnings: Strategic Momentum Outpaces Short-Term Setbacks - AInvest

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics Inc (HRTX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada

Aug 09, 2025

Aug 09, 2025

TD Asset Management Inc Acquires New Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics Reports Strong Q2 2025 Results - TipRanks

Aug 09, 2025

Aug 09, 2025

Heron Therapeutics: Needham Adjusts Price Target to $3.00 - AInvest

Aug 09, 2025

Aug 08, 2025

Heron Therapeutics Raises EBITDA Guidance to $9M-$13M for 2025 Amid Restructuring and ZYNRELEF J-code Milestone - AInvest

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics HRTX Q2 2025 Earnings Preview Upside Potential Amid Product Expansion - AInvest

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025 - The Malaysian Reserve

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics' Q2 2025 Performance and Strategic Realignments: A Blueprint for Long-Term Growth - AInvest

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:HRTX) - Seeking Alpha

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics raises adjusted EBITDA guidance to $9M-$13M for 2025 amid commercial restructuring and ZYNRELEF J-code milestone - MSN

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Reschedules Q2 2025 Earnings Release and Conference Call to August 8, 2025 - AInvest

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Plummets 28%: What's Fueling the Sudden Sell-Off? - AInvest

Aug 08, 2025

Aug 08, 2025

Transcript : Heron Therapeutics, Inc., Q2 2025 Earnings Call, Aug 08, 2025 - MarketScreener

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Trims Debt And Lifts Yearly Outlook - Finimize

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Heron Therapeutics faces Q2 2025 earnings miss, stock drops - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Tightens Its Belt And Lifts Its Outlook - Finimize

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Q2 2025 slides: Revenue grows, guidance raised despite stock plunge - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 08, 2025

Heron Craters on Q2 Figures - Baystreet.ca

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Aug 08, 2025

Aug 08, 2025

Heron Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 08, 2025